A Clinical To Study Evaluate The Effect of Meha Mudgar Rasa in Diabetic Neuropathy
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2024/04/066544
- Lead Sponsor
- Parul Institute of Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Age between 40 and 75 years (both years inclusive).
2. Both male and female.
3. Known case of Diabetes mellitus with symptoms of Diabetic Neuropathy.
4. Patients with good to moderate glycemic control.
5. Known case of Diabetes mellitus with MNSI Questionnaire score of more than or equal to 7 and MNSI Examination
Score of =2.5.32
6. Patients showing altered perception of sensory stimulus on the basis of Biothesiometer.
1. Known case of Rheumatic disease.
2. Known case of Vitamin deficiency.
3. Alcoholism and any other drug abuse.
4. Known case of Paraneoplastic disorder and any other SOL causing nerve dysfunction.
5. Known case of Cerebral vascular disease.
6. Known case of Parkinsonism and any other nerve degenerative disorders.
7. Known case of Leprosy, HIV-AIDS, sexually transmitted disease, and other immune-compromised conditions.
8. Patients with acute complications of Diabetes mellitus.
9. Known case of uncontrolled Hypertension.
10. Patients with known allergy to any drug ingredients of study medicine in trial group and control group
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of effect of Meha Mudgara Rasa with Pregabalin in patients of Diabetic neuropathy on the basis of Biothesiometer and Michigan Neuropathy Screening Instrument.Timepoint: Baseline, Day 15, Day 30, day 45, Day 60, Day 75, Day 90
- Secondary Outcome Measures
Name Time Method Compare the efficacy of Meha Mudgara Rasa with Pregabalin in patients of Diabetic neuropathy on the basis of symptoms observed in patientsTimepoint: Baseline, Day 15, Day 30, day 45, Day 60, Day 75, Day 90;Compare the safety of Meha Mudgara Rasa and Pregabalin on the basis of adverse events and biochemical parameters –haemogram, renal and hepatic function test, urine routine and microscopic and glycosylated hemoglobin.Timepoint: Baseline, Day 90